SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008990
Filing Date
2022-05-10
Accepted
2022-05-10 16:18:23
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cue-20220331.htm   iXBRL 10-Q 1772133
2 EX-10.3 cue-ex10_3.htm EX-10.3 26622
3 EX-31.1 cue-ex31_1.htm EX-31.1 16065
4 EX-31.2 cue-ex31_2.htm EX-31.2 16167
5 EX-32.1 cue-ex32_1.htm EX-32.1 14896
6 GRAPHIC img76097529_0.jpg GRAPHIC 30751
  Complete submission text file 0000950170-22-008990.txt   7750429

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cue-20220331_pre.xml EX-101.PRE 390337
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cue-20220331_def.xml EX-101.DEF 243729
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cue-20220331.xsd EX-101.SCH 59486
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cue-20220331_cal.xml EX-101.CAL 44275
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cue-20220331_lab.xml EX-101.LAB 492326
64 EXTRACTED XBRL INSTANCE DOCUMENT cue-20220331_htm.xml XML 1218312
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 22909921
SIC: 2834 Pharmaceutical Preparations